Health care costs of persons with diabetes prior to and following hospitalization in Argentina;Costos de atención médica de personas con diabetes anteriores y posteriores a su hospitalización en Argentina

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 20, Issue 6, 2006, Pages 361-368

  Caporale, Joaquín E ^a   Calvo, Héctor ^b   Gagliardino, Juan J ^a  

^a University of La Plata CONICET   (Argentina)

^b UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

Author keywords

Argentina; Cost of illness; Diabetes mellitus; Disease management; Hospital costs; Hospitalization

Indexed keywords

CARDIOVASCULAR DISEASE; DIABETES; HEALTH EXPENDITURE; HEALTH INSURANCE; HEALTH RISK; HEALTH SURVEY; HOSPITAL SECTOR; RISK FACTOR;

ARGENTINA; SOUTH AMERICA;

EID: 34247230112     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/s1020-49892006001100001     Document Type: Article

References (33)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414-31.
2. Selby J, Ray GT, Zhang D, Colby CJ. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care. 1997;20:1396-402.
3. Jonsson B; CODE-2 Advisory Board. Revealing the cost of Type II diabetes in Europe. Diabetologia. 2002;45:S5-12.
4. Laing W, Williams DRR. Diabetes: a model for health care management. Office of Health Economics (Series No 92, ISSN 04738837), London, 1989.
5. American Diabetes Association: Economic Costs of Diabetes in the U.S. in 2002. Diabetes Care. 2003;26:917-32.
6. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329:977-86.
7. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;52:854-65.
8. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348: 383-93.
9. Gagliardino JJ, Williams R, Clark CM Jr. Using hospitalization rates to track the economic costs and benefits of improved diabetes care in the Americas: a proposal for health policy makers. Diabetes Care. 2000;23:1844-6.
10. Jönsson B. The economic impact of diabetes. Diabetes Care. 1998;Suppl 3:C7-10.
11. Henriksson F, Jönsson B. Diabetes: the cost of illnes in Sweden. J Intern Med. 1998;244:461-8.
12. Norlund A, Apelqvist J, Bitzen PO, Nyberg P, Schersten B. Cost of illness of adult diabetes mellitus underestimated if comorbidity is not considered. J Intern Med. 2001;250:57-65.
13. Chronic Complications of Diabetes. En: Alberti KGMM, Zimmet P, DeFronzo RA, Keen H, eds. International Textbook of Diabetes Mellitus, Second edition. Chichester: John Wiley & Sons Ltd; 1997. Pp. 1283-531.
14. Gagliardino JJ, Martella A, Etchegoyen GS, Caporale JE, Guidi ML, Olivera EM, et al. Hospitalization and re-hospitalization of people with and without diabetes in La Plata, Argentina: comparison of their clinical characteristics and costs. Diabetes Res Clin Fract. 2004;65:51-9.
15. Gagliardino JJ, Olivera ME, Etchegoyen GS, Gonzalez C, Guidi ML. Evaluación y costos del proceso de atención de pacientes diabéticos. Medicina (Buenos Aires). 2000;60:880-8.
16. Gagliardino JJ, Olivera E, Etchegoyen GS, Guidi ML, Caporale JE, Martella A, et al. PROPAT: A study to improve the quality and reduce the cost of diabetes care. Diabetes Res Clin Pract. 2006;72:284-91.
17. Gagliardino J, Olivera E. The regions and their health care systems: Latin American. In: Economics of Diabetes and Diabetes Care. A report of the Diabetes Health Economics Study Group. Gruber W, Lander T, Leese B, Songer T, Williams H, Eds. 1997;51-9.
18. Gagliardino JJ, Etchegoyen G, PEDNID-LA Research Group. A model education program for people with type 2 diabetes: a cooperative Latin American implementation study (PEDNIDLA). Diabetes Care. 2001;24:1001-7.
19. Gagliardino JJ, De La Hera M, Siri F; Grupo de Investigación de la Red Qualidiab. Evaluación de la calidad de la asistencia al paciente diabético en América Latina. Rev Panam Salud Publica. 2001;10:309-17.
20. Currie CJ, Morgan CL, Peters JR. The epidemiology and cost of inpatient care for peripheral vascular disease, infection, neuropathy, and ulceration in diabetes. Diabetes Care. 1998;21:42-8.
21. Bouter KP, Storm AJ, de Groot RR, Uitslager R, Erkelens DW, Diepersloot RJ. The diabetic foot in Dutch hospitals: epidemiological features and clinical outcome. Eur J Med. 1993;2: 215-8.
22. Krop JS, Saudek CD, Weller WE, Powe NR, Shaffer T, Anderson GF. Predicting expenditures for Medicare beneficiaries with diabetes. A prospective cohort study from 1994 to 1996. Diabetes Care. 1999;22:1660-6.
23. Jiang HJ, Stryer D, Friedman B, Andrews R. Multiple hospitalizations for patients with diabetes. Diabetes Care. 2003;26:1421-6.
24. Wilson BE, Sharma A. Public cost and access to primary care for hyperglycemic emergen cies, Clark County, Nevada. J. Community Health. 1995;20:249-56.
25. Pedersen TR. Coronary artery disease: the Scandinavian Simvastatin Survival Study experience. Am J Cardiol. 1998;82:53T-56T.
26. Moss S, Klein R, Klein B. Risk factors for hospitalization in people with diabetes. Arch Intern Med. 1999;159:2053-7.
27. Menzin J, Langley-Hawthorne C, Friedman M, Boulanger L, Cavanaugh R. Potential short-term economic benefits of improved glycemic control: a managed care perspective. Diabetes Care. 2001;24:51-5.
28. Karter A, Stevens M, Herman WH, Ettner S, Marrero DG, Safdford MM, et al. Translating Research Into Action for Diabetes Study Group. Out-of-pocket costs and diabetes prevention services: The Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care. 2003;26:2294-9.
29. Arredondo A, Zuniga A. Economic consequences of epidemiological changes in diabetes in middle-income countries: The Mexican Case. Diabetes Care. 2004;27:104-9.
30. Hillege HL, Janssen WM, Bak AA, Diercks GF, Grobbee DE, Crijns HJ et al.; Prevend Study Group. Microalbuminuria is common, also in a non diabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med. 2001;249:519-26.
31. Selby JV, Ray GT, Zhang D, Colby CJ. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care. 1997;20:1396-402.
32. Hart WM, Espinosa C, Rovira J. Costs of known diabetes mellitus in Spain. Med Clin (Bare). 1997;109:289-93.
33. Kangas T, Aro S, Koivisto VA, Salinto M, Laakso M, Reunanen A. Structure and costs of health care of diabetic patients in Finland. Diabetes Care. 1996;19:494-7.